NATCOPHARM.BONATCOPHARM.BOBSE

Revenue (LTM)

$44.3B

+10.7% YoY

Net Income (LTM)

$18.9B

+35.8% YoY

Free Cash Flow

$14.3B

Revenue CAGR (5Y)

+18.3%

Marginsimproving

FCF$14.3B

Profitable

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Revenue	20,561	19,462↓5.3%	27,085↑39.2%	40,020↑47.8%	44,319↑10.7%
Gross Profit	15,243	13,617↓10.7%	20,541↑50.8%	32,533↑58.4%	37,045↑13.9%
Operating Income	9,311	6,930↓25.6%	14,916↑115.2%	25,962↑74.1%	30,003↑15.6%
Net Income	4,409	1,700↓61.4%	7,153↑320.8%	13,883↑94.1%	18,854↑35.8%
EBITDA	6,066	2,600↓57.1%	9,669↑271.9%	17,506↑81.1%	21,442↑22.5%
EPS Diluted	24.16	9.32↓61.4%	39.18↑320.4%	77.34↑97.4%	105.26↑36.1%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Cash & Equivalents	258	1,111↑330.6%	1,319↑18.7%	704↓46.6%	21,760↑2990.9%
Total Current Assets	23,373	24,972↑6.8%	30,003↑20.1%	40,235↑34.1%	52,700↑31.0%
Total Assets	47,919	51,091↑6.6%	56,574↑10.7%	69,063↑22.1%	86,308↑25.0%
Total Current Liabilities	5,256	7,104↑35.2%	6,831↓3.8%	9,728↑42.4%	9,435↓3.0%
Total Liabilities	6,685	8,455↑26.5%	-34,800↓511.6%	10,532↑130.3%	10,185↓3.3%
Total Equity	41,216	42,636↑3.4%	48,738↑14.3%	58,531↑20.1%	76,070↑30.0%
Total Debt	2,839	4,320↑52.2%	1,761↓59.2%	3,861↑119.3%	2,794↓27.6%
Net Debt	2,581	3,209↑24.3%	348↓89.2%	3,157↑807.2%	-18,966↓700.8%

Metric	Mar 21	Mar 22	Mar 23	Mar 24	Mar 25
Operating Cash Flow	2,988	465↓84.4%	8,491↑1726.0%	12,116↑42.7%	16,968↑40.0%
Capital Expenditure	-2,546	-2,427↑4.7%	-2,056↑15.3%	-3,394↓65.1%	-4,011↓18.2%
Free Cash Flow	442	-1,962↓543.9%	6,435↑428.0%	8,722↑35.5%	14,280↑63.7%
Stock-Based Comp	126	22↓82.5%	0	0	0
Net Change in Cash	60	853↑1321.7%	208↓75.6%	-615↓395.7%	496↑180.7%

Values in millions except EPS · Ratios shown as percentages · Click any metric to drill down

Explore More

Filter and sort all 500 stocks

Today's biggest gainers and losers

Visual sector performance